PTCA catheter Pantera® Lux®

small vesselcoronaryballoon

Pantera Lux Coronary Drug-Coated Balloon (DCB) is indicated for balloon dilatation for in-stent restenosis, de novo lesions, acute or impending vascular occlusion and treatment of small vessel disease. Product Highlights Clinically proven solution For in-stent-restenosis and further indications Lux®coating technology For rapid drug absorption Excellent deliverability Lowest crossing profile for better push and easier cross Clinically proven solution Clinical outcomes from multiple studies including randomized controlled trials like BIOLUX RCT, ISARDESIRE 4 and PEBSI show high efficacy and safety for both in-stent restenotic and de novo lesions. More than 3,900 patients treated in clinical studies Pantera Lux DCB has proven efficacy and safety in multiple clinical trials investigating coronary drug-coated balloons for various implant-free treatment options. Lux® coating technology for rapid drug absorption The Lux coating technology blends paclitaxel with BTHC, a rapidly metabolized, safe and biocompatible excipient, thus improving bioavailability at the target site.13 Prolonged tissue retention at the target site Following one application of the Pantera Lux DCB, paclitaxel can be readily detected in the treated region beyond 7 days in animal tissue. Excellent deliverability Pantera Lux DCB, with its lowest crossing profile, provides better pushability and easier crossability. Clinical Highlights BIOLUX RCT⁴ DCB is confirmed as a viable treatment option for ISR with the advantage of avoiding an additional stent layer Prospective, multi-center, randomized, controlled clinical trial